Cargando…

Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines

BACKGROUND: To achieve licensure, interventions typically must demonstrate efficacy against a primary outcome in a randomized clinical trial. However, selecting a single primary outcome a priori is challenging. Incorporating data from multiple and related outcomes might help to increase statistical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prunas, Ottavia, Willemsen, Joukje E., Bont, Louis, Pitzer, Virginia E., Warren, Joshua L., Weinberger, Daniel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934779/ https://www.ncbi.nlm.nih.gov/pubmed/36798386 http://dx.doi.org/10.1101/2023.02.07.23285596

Ejemplares similares

Local variations in the timing of RSV epidemics
por: Noveroske, Douglas B., et al.
Publicado: (2016)

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022)

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
por: Prunas, Ottavia, et al.
Publicado: (2021)

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
por: Prunas, Ottavia, et al.
Publicado: (2022)

Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study
por: Willemsen, Joukje E., et al.
Publicado: (2023)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups
por: Zheng, Zhe, et al.
Publicado: (2022)

Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children
por: Zheng, Zhe, et al.
Publicado: (2022)

Incorporating efficacy data from initial trials into subsequent evaluations: Application to vaccines against respiratory syncytial virus
por: Warren, Joshua L., et al.
Publicado: (2023)

A systematic review on global RSV genetic data: Identification of knowledge gaps
por: Langedijk, Annefleur C., et al.
Publicado: (2021)

Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series
por: Löwensteyn, Yvette N., et al.
Publicado: (2022)

Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls
por: Prunas, Ottavia, et al.
Publicado: (2021)

Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
por: Zheng, Zhe, et al.
Publicado: (2021)

Community factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study
por: Zheng, Zhe, et al.
Publicado: (2021)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

Quantifying the RSV immunity debt following COVID-19: a public health matter
por: Billard, Marie-Noëlle, et al.
Publicado: (2022)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union
por: van Beek, Dianne, et al.
Publicado: (2013)

Relative timing of respiratory syncytial virus epidemics in summer 2021 across the United States was similar to a typical winter season
por: Zheng, Zhe, et al.
Publicado: (2022)

Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk
por: den Hartog, Gerco, et al.
Publicado: (2014)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017−2018 INFORM-RSV Study
por: Tabor, David E., et al.
Publicado: (2020)

Bayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015)

Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
por: Löwensteyn, Yvette N, et al.
Publicado: (2021)

Meeting Report: Harmonization of RSV therapeutics – from design to performance
por: Nair, Harish, et al.
Publicado: (2016)

Interim analysis incorporating short‐ and long‐term binary endpoints
por: Niewczas, Julia, et al.
Publicado: (2019)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study
por: Löwensteyn, Yvette N., et al.
Publicado: (2020)

Incorporating Information on Control Diseases Across Space and Time to Improve Estimation of the Population-level Impact of Vaccines
por: Shioda, Kayoko, et al.
Publicado: (2021)

The assessment of future RSV immunizations: How to protect all infants?
por: Bont, Louis, et al.
Publicado: (2022)

Assessment and optimization of respiratory syncytial virus prophylaxis in Connecticut, 1996–2013
por: Artin, Ben, et al.
Publicado: (2021)

Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing’s sarcoma
por: Dutton, P, et al.
Publicado: (2016)

The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States
por: Pitzer, Virginia E., et al.
Publicado: (2020)

Multiple preferred escape trajectories are explained by a geometric model incorporating prey’s turn and predator attack endpoint
por: Kawabata, Yuuki, et al.
Publicado: (2023)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo
por: Jacobino, Shamir R., et al.
Publicado: (2018)

External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: A retrospective Dutch cohort study
por: Vos, Laura M., et al.
Publicado: (2019)

International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures
por: Billard, Marie‐Noëlle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9h5i33p47h0e6cij2se0juqcm